| Primary |
| Breast Cancer Female |
100.0% |
|
|
| Secondary |
| Smoking Cessation Therapy |
16.7% |
| Drug Use For Unknown Indication |
8.1% |
| Hypersensitivity |
7.1% |
| Blood Cholesterol Increased |
6.6% |
| Hypertension |
6.6% |
| Product Used For Unknown Indication |
6.6% |
| Arthritis |
6.1% |
| Anxiety |
5.1% |
| Hormone Replacement Therapy |
5.1% |
| Depression |
4.0% |
| Osteoporosis |
4.0% |
| Suicide Attempt |
3.5% |
| Antiallergic Therapy |
3.0% |
| Crohn's Disease |
3.0% |
| Dyspepsia |
3.0% |
| Bladder Disorder |
2.5% |
| Epilepsy |
2.5% |
| Hernia |
2.5% |
| Affective Disorder |
2.0% |
| Aspergillosis |
2.0% |
|
| Suicide Attempt |
12.5% |
| Weight Decreased |
12.5% |
| Weight Increased |
7.3% |
| Rash Macular |
6.3% |
| Tremor |
6.3% |
| Nausea |
5.2% |
| Respiratory Arrest |
5.2% |
| Vomiting |
5.2% |
| Withdrawal Syndrome |
5.2% |
| Sedation |
4.2% |
| Somnolence |
4.2% |
| Visual Acuity Reduced |
4.2% |
| Malaise |
3.1% |
| Pyrexia |
3.1% |
| Swelling |
3.1% |
| Thyroid Function Test Abnormal |
3.1% |
| Visual Impairment |
3.1% |
| Breast Cancer Female |
2.1% |
| Completed Suicide |
2.1% |
| Convulsion |
2.1% |
|
| Concomitant |
| Smoking Cessation Therapy |
33.0% |
| Hypertension |
10.2% |
| Blood Cholesterol Increased |
6.1% |
| Pain |
5.1% |
| Fibromyalgia |
4.7% |
| Diabetes Mellitus |
4.4% |
| Drug Use For Unknown Indication |
4.4% |
| Thyroid Disorder |
3.7% |
| Glaucoma |
3.4% |
| Neuralgia |
3.1% |
| Arthritis |
3.0% |
| Depression |
2.8% |
| Hypersensitivity |
2.3% |
| Hormone Replacement Therapy |
2.3% |
| Anxiety |
2.1% |
| Bipolar Disorder |
1.9% |
| Blood Cholesterol |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Neuropathy Peripheral |
1.9% |
| Asthma |
1.7% |
|
| Nausea |
16.3% |
| Vomiting |
13.1% |
| Weight Increased |
11.5% |
| Drug Ineffective |
6.5% |
| Somnolence |
6.1% |
| Tremor |
4.8% |
| Weight Decreased |
4.8% |
| Malaise |
4.3% |
| Vision Blurred |
4.1% |
| Insomnia |
3.7% |
| Suicidal Ideation |
3.3% |
| Headache |
2.8% |
| Death |
2.6% |
| Pruritus |
2.6% |
| Rash |
2.6% |
| Oedema Peripheral |
2.4% |
| Renal Failure Acute |
2.2% |
| Unevaluable Event |
2.2% |
| Urticaria |
2.2% |
| Sleep Disorder |
2.0% |
|
| Interacting |
| Smoking Cessation Therapy |
36.4% |
| Insomnia |
13.6% |
| Convulsion |
7.6% |
| Chronic Obstructive Pulmonary Disease |
4.5% |
| Hypertension |
4.5% |
| Nicotine Dependence |
4.5% |
| Tobacco Abuse |
4.5% |
| Angiopathy |
3.0% |
| Mineral Supplementation |
3.0% |
| Neuralgia |
3.0% |
| Asthma |
1.5% |
| Breast Cancer |
1.5% |
| Bronchitis |
1.5% |
| Dyspepsia |
1.5% |
| Grand Mal Convulsion |
1.5% |
| Kidney Infection |
1.5% |
| Leukaemia |
1.5% |
| Neoplasm Malignant |
1.5% |
| Nerve Block |
1.5% |
| Schizophrenia |
1.5% |
|
| Weight Increased |
24.0% |
| Myoclonus |
12.0% |
| Vision Blurred |
10.0% |
| Drug Interaction |
6.0% |
| Vomiting |
6.0% |
| Nausea |
4.0% |
| Suicidal Ideation |
4.0% |
| Syncope |
4.0% |
| Transient Ischaemic Attack |
4.0% |
| Tremor |
4.0% |
| Visual Acuity Reduced |
4.0% |
| Euphoric Mood |
2.0% |
| Flatulence |
2.0% |
| Nervous System Disorder |
2.0% |
| Nightmare |
2.0% |
| Psychomotor Hyperactivity |
2.0% |
| Suicidal Behaviour |
2.0% |
| Thinking Abnormal |
2.0% |
| Urticaria |
2.0% |
| Vertigo |
2.0% |
|
